Strengthening Clinical Operations in Southeast AsiaC&R Research has entered into strategic partnerships with Vietnamese CROs, VietStar Biomedical Research and Smart Research. Through these collaborations, we aim to strengthen multi-country clinical trial operations in Southeast Asia, enhance local execution capabilities, and expand our clinical competitiveness across Asia.For more details, please refer to the link below.Read the text | Ref: THE BIO

First Domestic Adoption of Taimei AI Agent Secured with 1-year ExclusivityC&R Research has signed a comprehensive agreement with Taimei Technology to drive AI-based clinical innovation.With the first domestic adoption of the Taimei AI Agent and a one-year exclusivity secured,the company is set to advance the implementation of an AI-powered clinical trial operation system.For more details, please refer to the link below.Read the text | Ref: Edaily

   MRD Biomarkers for Tracking Invisible Cancer: Spotlight on FDA Accelerated Approval StrategiesC&R Research host its 5th webinar on April 29 under the theme,'Beyond Response: How MRD is Transforming Cancer Treatment and Drug Development'.The session will highlight the scientific significance of MRDand evolving clinical development strategies aligned with global regulatory standards.For more details, please refer to the link below.Read the text | Ref: Edaily

    Across Korea and Indonesia...Accelerating Global Clinical ExpansionC&R Research has initiated a large-scale Phase 3 MRCT in collaboration with Daewoong Pharmaceutical.Through this study across Korea and Indonesia, C&R Research is accelerating its global expansion.For more details, please refer to the link below.Read the text | Ref: The Yakup News

    CDSA Division established to strengthen data-centric clinical operationsC&R Research has appointed biostatistics expert Byungkwan Park as Executive Directorand established the CDSA Division to strengthen its data-driven clinical operations.For more details, please refer to the link below.Read the text | Ref: Hankyung

     Supporting overseas trial participation and attracting global projects to strengthen Korea's clinical trial competitivenessC&R Research has signed an MOU with the Korea National Enterprise for Clinical Trials(KoNECT) to expand global clinical trials.Leveraging its global clinical experience and network,the company will support Korean companies’ overseas expansion and further strengthen the clinical trial ecosystem.For more details, please refer to the link below.Read the text | Ref: The Yakup News